• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.

作者信息

Larkin Howard

出版信息

JAMA. 2024 Jan 23;331(4):277-279. doi: 10.1001/jama.2023.25115.

DOI:10.1001/jama.2023.25115
PMID:38150239
Abstract
摘要

相似文献

1
What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.关于美国心脏协会（AHA）新的心血管疾病风险计算器PREVENT，你需要了解的内容。
JAMA. 2024 Jan 23;331(4):277-279. doi: 10.1001/jama.2023.25115.
2
Highlights From AHA 2023-New Risk Calculator, Semaglutide and CVD, and More.美国心脏协会2023年亮点——新风险计算器、司美格鲁肽与心血管疾病等
JAMA. 2023 Dec 19;330(23):2237-2240. doi: 10.1001/jama.2023.22707.
3
Prevalence of the American Heart Association's "ideal cardiovascular health" metrics in a rural, cross-sectional, community-based study: the Heart of New Ulm Project.美国心脏协会“理想心血管健康”指标在农村横断面社区研究中的流行情况：新乌尔姆心脏项目。
J Am Heart Assoc. 2013 Apr 25;2(3):e000058. doi: 10.1161/JAHA.113.000058.
4
Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.循证决策：美国心脏协会战略政策组合评估：美国心脏协会政策声明
Circulation. 2016 May 3;133(18):e615-53. doi: 10.1161/CIR.0000000000000410. Epub 2016 Apr 4.
5
AHA's new strategic impact goal designed to curb epidemic of cardiovascular disease and stroke.美国心脏协会旨在遏制心血管疾病和中风流行的新战略影响目标。
Circulation. 1999 May 11;99(18):2360. doi: 10.1161/01.cir.99.18.2360.
6
The Power of Patient Stories to Inspire Us to Prevent Cardiovascular Disease and Death: Personal Reflections on the AHA's Scientific Sessions 2021.患者故事激励我们预防心血管疾病和死亡的力量：对美国心脏协会2021年科学会议的个人反思
Circulation. 2022 Feb;145(5):e143-e145. doi: 10.1161/CIRCULATIONAHA.121.058716. Epub 2022 Jan 31.
7
Translating research into practice for healthcare providers: the American Heart Association's strategy for building healthier lives, free of cardiovascular diseases and stroke.将研究成果转化为医疗服务提供者的实践：美国心脏协会打造无心血管疾病和中风的健康生活的策略。
Circulation. 2008 Aug 5;118(6):687-96. doi: 10.1161/CIRCULATIONAHA.108.189934. Epub 2008 Jul 14.
8
New Cardiovascular Disease Risk Calculator Could Eliminate the Need for Statins for Millions.新型心血管疾病风险计算器或可使数百万患者无需服用他汀类药物。
JAMA. 2024 Jul 16;332(3):186-187. doi: 10.1001/jama.2024.8590.
9
Assessing the Impact of the American Heart Association's Research Portfolio: A Scientific Statement From the American Heart Association.评估美国心脏协会研究组合的影响：美国心脏协会的科学声明。
Circulation. 2022 Nov;146(18):e246-e256. doi: 10.1161/CIR.0000000000001094. Epub 2022 Sep 22.
10
International Initiatives of the American Heart Association: Original Concepts, Present Programs, and Future Focus: A Science Advisory From the American Heart Association.美国心脏协会的国际倡议：原始理念、现行计划和未来重点：美国心脏协会的科学咨询。
Circulation. 2024 Sep 17;150(12):e259-e266. doi: 10.1161/CIR.0000000000001266. Epub 2024 Aug 15.

引用本文的文献

1
Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome.一种新出现的威胁：心肾代谢综合征的定义、分类、诊断及管理
Am J Cardiovasc Drugs. 2025 Aug 26. doi: 10.1007/s40256-025-00761-w.
2
External Validation of the Veterans Affairs Women Cardiovascular Disease Risk Score to Nonveteran Women.退伍军人事务部女性心血管疾病风险评分在非退伍军人女性中的外部验证
JACC Adv. 2025 Aug 12;4(9):102060. doi: 10.1016/j.jacadv.2025.102060.
3
LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway.
基于冠状动脉钙化的低密度脂蛋白胆固醇目标：推进2022年美国心脏病学会专家共识决策路径中的图6
Am J Prev Cardiol. 2025 Jun 26;23:101047. doi: 10.1016/j.ajpc.2025.101047. eCollection 2025 Sep.
4
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.胰高血糖素样肽-1受体激动剂在心肌梗死及降低动脉粥样硬化性心血管疾病风险中的应用：治疗所需人数、疗效及安全性的综合荟萃分析
Cardiovasc Diabetol. 2025 Jul 12;24(1):285. doi: 10.1186/s12933-025-02840-3.
5
Reply to: [Letter to the Editor].回复：[致编辑的信]。
Health Equity. 2024 Sep 12;8(1):636-638. doi: 10.1089/heq.2024.0049. eCollection 2024.
6
Harnessing Electronic Health Records and Artificial Intelligence for Enhanced Cardiovascular Risk Prediction: A Comprehensive Review.利用电子健康记录和人工智能增强心血管疾病风险预测：一项全面综述。
J Am Heart Assoc. 2025 Mar 18;14(6):e036946. doi: 10.1161/JAHA.124.036946. Epub 2025 Mar 13.
7
Clinical decision support to improve primary care obesity management in adults with diabetes: Clinic-randomized study design.改善成人糖尿病患者初级保健肥胖管理的临床决策支持：临床随机研究设计
Contemp Clin Trials. 2025 Mar;150:107830. doi: 10.1016/j.cct.2025.107830. Epub 2025 Feb 1.
8
Comprehensive Review of Lipid Management in Chronic Kidney Disease and Hemodialysis Patients: Conventional Approaches, and Challenges for Cardiovascular Risk Reduction.慢性肾脏病和血液透析患者血脂管理的全面综述：传统方法及降低心血管风险面临的挑战
J Clin Med. 2025 Jan 20;14(2):643. doi: 10.3390/jcm14020643.
9
A novel, machine-learning model for prediction of short-term ASCVD risk over 90 and 365 days.一种用于预测90天和365天短期动脉粥样硬化性心血管疾病（ASCVD）风险的新型机器学习模型。
Front Digit Health. 2024 Nov 1;6:1485508. doi: 10.3389/fdgth.2024.1485508. eCollection 2024.
10
Achieving equitable access to incretin-based therapies in cardiovascular care.在心血管护理中实现对基于肠促胰岛素疗法的公平获取。
Am Heart J Plus. 2024 Sep 10;46:100455. doi: 10.1016/j.ahjo.2024.100455. eCollection 2024 Oct.